October 2016, 24:7
15 November 2016
2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary
Dyslipidemia Guidelines 2015
Adriel E. Guerrero
The Philippine Heart Association, the Philippine Lipid and Atherosclerosis Society, and the Philippine Society of Endocrinology, Diabetes, and Metabolism, collaborated to develop the 2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines (2015 CPG). These guidelines are meant to update the 2005 Clinical Practice Guidelines on the Management of Dyslipidemia in the Philippines (2005 CPG). A panel of experts in the fields of dyslipidemia, cardiology, endocrinology and epidemiology were assembled to comprise the technical research committee (TRC) tasked to review available clinical evidence on dyslipidemia management. The main objective for this document is to develop clinical guidelines in the management of Filipino patients who are diagnosed with elevated cholesterol. This may infl uence standards and national policies for optimal patient care and cardiovascular health.
Statin Therapy - Ezetimibe - Clinical Question - Familial Hypercholesterolemia - Familial Hypercholesterolemia
©Philippine Heart Association, Inc. and Philippine College of Cardiology. This article is published with Open Access by ASEAN Federation of Cardiology.
Correspondence: Adriel E. Guerrero, MD, Philippine Heart Association, Council on Preventive Cardiology. Email: